C11-Acetate PET/CT Imaging in Prostate Adenocarcinoma, Study of Impact in Initial Treatment and in Treatment Monitoring
by on Thursday, February 9th, 2012 | No Comments
Conditions: Prostate Cancer; Prostate Adenocarcinoma
Intervention: Drug: C11-Sodium Acetate
Sponsor: Arizona Molecular Imaging Center
Not yet recruiting – verified February 2012